Ignite Creation Date:
2025-12-25 @ 3:31 AM
Ignite Modification Date:
2026-06-30 @ 9:11 PM
Study NCT ID:
NCT04964505
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-08-01
First Post:
2021-07-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Uproleselan, Azacitidine, and Venetoclax for the Treatment of Treatment Naive Acute Myeloid Leukemia
Sponsor:
Brian Jonas
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
UCDCC#294
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None